These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6540873)

  • 1. Amastatin potentiates the behavioral effects of vasopressin and oxytocin in mice.
    Meisenberg G; Simmons WH
    Peptides; 1984; 5(3):535-9. PubMed ID: 6540873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
    Croiset G; De Wied D
    Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin analgesia: specificity of action and non-opioid effects.
    Kordower JH; Bodnar RJ
    Peptides; 1984; 5(4):747-56. PubMed ID: 6494025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral responses to intracerebroventricularly administered neurohypophyseal peptides in mice.
    Delanoy RL; Dunn AJ; Tintner R
    Horm Behav; 1978 Dec; 11(3):348-62. PubMed ID: 753699
    [No Abstract]   [Full Text] [Related]  

  • 5. Excitation of neurones in the rat paraventricular nucleus in vitro by vasopressin and oxytocin.
    Inenaga K; Yamashita H
    J Physiol; 1986 Jan; 370():165-80. PubMed ID: 3007746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin and amastatin induce V(1)-receptor-mediated suppression of excitatory transmission in the rat parabrachial nucleus.
    Chen X; Pittman QJ
    J Neurophysiol; 1999 Oct; 82(4):1689-96. PubMed ID: 10515959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxytocin but not vasopressin facilitates social recognition following injection into the medial preoptic area of the rat brain.
    Popik P; van Ree JM
    Eur Neuropsychopharmacol; 1991 Dec; 1(4):555-60. PubMed ID: 1668316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine antagonism does not potentiate the effects of oxytocin and vasopressin on prolactin secretion.
    Pan JT; Mai LM
    Life Sci; 1990; 47(26):2443-50. PubMed ID: 2263168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced pressor responses to ICV vasopressin after pretreatment with oxytocin.
    Poulin P; Komulainen A; Takahashi Y; Pittman QJ
    Am J Physiol; 1994 Feb; 266(2 Pt 2):R592-8. PubMed ID: 8141420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Fos expression following microinjection of oxytocin or vasopressin in the prairie vole brain.
    Gingrich BS; Huot RL; Wang Z; Insel TR
    Ann N Y Acad Sci; 1997 Jan; 807():504-5. PubMed ID: 9071383
    [No Abstract]   [Full Text] [Related]  

  • 11. Haemodynamic effects of arginine-vasopressin microinjections into the nucleus tractus solitarius: a comparative study of vasopressin, a selective vasopressin receptor agonist and antagonist, and oxytocin.
    Vallejo M; Carter DA; Lightman SL
    Neurosci Lett; 1984 Dec; 52(3):247-52. PubMed ID: 6521969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite effects of oxytocin and vasopressin on avoidance behaviour and hippocampal theta rhythm in the rat.
    Bohus B; Urban I; van Wimersma Greidanus TB; de Wied D
    Neuropharmacology; 1978; 17(4-5):239-47. PubMed ID: 652136
    [No Abstract]   [Full Text] [Related]  

  • 13. Potentiation of vasopressin analgesia in rats treated neonatally with monosodium glutamate.
    Bodnar RJ; Truesdell LS; Nilaver G
    Peptides; 1985; 6(4):621-6. PubMed ID: 4070021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oxytocin, arginine-vasopressin and lysine-vasopressin on insulin and glucagon secretion in sheep.
    Mineo H; Ito M; Muto H; Kamita H; Hyun HS; Onaga T; Yanaihara N
    Res Vet Sci; 1997; 62(2):105-10. PubMed ID: 9243706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurohypophysial peptides and the hippocampus. II. Excitation of rat hippocampal neurones by oxytocin and vasopressin applied in vitro.
    Tiberiis BE; McLennan H; Wilson N
    Neuropeptides; 1983 Dec; 4(1):73-86. PubMed ID: 6669225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin reduces release from vasopressin-neurons and oxytocin-neurons by acting on V2-like receptors.
    Cheng SW; North WG
    Brain Res; 1989 Feb; 479(1):35-9. PubMed ID: 2522339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An anxiolytic action of oxytocin is enhanced by estrogen in the mouse.
    McCarthy MM; McDonald CH; Brooks PJ; Goldman D
    Physiol Behav; 1996 Nov; 60(5):1209-15. PubMed ID: 8916173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine vasopressin and oxytocin increase intracellular calcium and cAMP in human glomerular epithelial cells in culture.
    Späth M; Pavenstädt H; Petersen J; Schollmeyer P
    Kidney Blood Press Res; 1996; 19(2):81-6. PubMed ID: 8871886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxytocin and vasopressin hexapeptide fragments have opposing influences on conditioned freezing behavior.
    Stoehr JD; Cramer CP; North WG
    Psychoneuroendocrinology; 1992; 17(2-3):267-71. PubMed ID: 1438652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutual regulation of vasopressin- and oxytocin-induced glucagon secretion in V1b vasopressin receptor knockout mice.
    Fujiwara Y; Hiroyama M; Sanbe A; Yamauchi J; Tsujimoto G; Tanoue A
    J Endocrinol; 2007 Feb; 192(2):361-9. PubMed ID: 17283236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.